CSTONE PHARMA-B(02616) will show three independently developed pipeline achievements on the international academic stage.

Basestone Pharmaceuticals-B (02616) announced that the preclinical research results of three self-developed pipeline projects of the company have been selected for the poster presentation session at the 2026 Annual Meeting of the American Association for Cancer Research (AACR). This conference is one of the most influential academic conferences in the field of global cancer research. The current annual meeting will be held from April 17 to April 22, 2026, at the San Diego Convention Center in California, USA. The relevant research abstracts will be published in the official journal "Cancer Research" of AACR on April 3, 2026.